News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lind Kevin Robert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Lind Kevin Robert (CEO) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 195,000 options to buy
@ $4.2, valued at
$819k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Lind Kevin Robert (Executive VP and CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,091 shares
@ $47.32, valued at
$146.3k
Exercised 6,300 options to buy
@ $0 |
|
| 01/08/2019 |
4
| Lind Kevin Robert (Executive VP and CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $40.94, valued at
$3.1M
Granted 12,600 options to buy
@ $0 |
|
| 01/22/2018 |
4
| Lind Kevin Robert (Executive VP and CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 130,000 options to buy
@ $35.6, valued at
$4.6M
|
|
| 02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2016 |
4
| Lind Kevin Robert (Executive VP and CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 800,000 options to buy
@ $1.94, valued at
$1.6M
|
|
|
|